Effects of N-nitrosofenfluramine, a component of Chinese dietary supplement for weight loss, on CD-1 mice.
Many cases of hepatopathy including deaths have frequently occurred after ingestion of Chinese dietary supplements for weight loss containing N-nitrosofenfluramine (N-fen), a nitroso derivative of fenfluramine (Fen), which was used for the treatment of obesity in the United States. Since Fen decreases appetite by decreasing the serotonin level and exhibits an antibiotic effect, N-fen may have been added, expecting a similar effect. Thus, we synthesized N-fen and orally administered it to mice, and investigated its effect on the liver as well as on the cerebral serotonin nervous system to investigate whether N-fen exhibits an anorectic effect. Three doses of N-fen were orally administered once daily to mice for 1 week. No significant changes in body weight, food intake, and general condition were noted. The liver and kidney weights were significantly increased. On blood chemistry, alkaline phosphatase, aspartate aminotransferase, and alanine aminotransferase activities were increased, and total bilirubin and albumin were slightly decreased. On histopathological examination, acidophilic changes and mild cellular swelling were noted in the liver. The liver drug-metabolizing enzyme (P-450) level was significantly higher. The effect of N-fen on the serotonin (5HT) nervous system was examined by quantitative autoradiography of the mouse brain, and it was found that N-fen did not decrease the 5HT nerve activity. Effects of reuptake and release of monoamine neurotransmitters [dopamine (DA), 5HT, and norepinephrine (NE)] were investigated. N-fen inhibited a little 5HT reuptake, and did not inhibit reuptakes of DA and NE. Moreover, N-fen did not affect release of the three monoamines. The above findings suggested that N-fen did not exhibit a serotonin nerve fiber-mediated anorectic effect in mice, but induced hepatopathy.
Satoh
Kanako
K
Department of Environmental Health and Toxicology, Tokyo Metropolitan Institute of Public Health, 24-1 Hyakunincho 3-chome, 169-0073 Shinjuku-ku, Tokyo, Japan. Kanako_Satou@member.metro.tokyo.jp
Nonaka
Ryouichi
R
Tada
Yukie
Y
Fukumori
Nobutaka
N
Ogata
Akio
A
Yamada
Arisa
A
Satoh
Tsuyoshi
T
Nagai
Fumiko
F
D000284:Administration, Oral; D000818:Animals; D019440:Anti-Obesity Agents / Q000633:toxicity*; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D056486:Chemical and Drug Induced Liver Injury / Q000201:enzymology / Q000209:etiology / Q000473:pathology; D003577:Cytochrome P-450 Enzyme System / Q000187:drug effects / Q000378:metabolism; D019587:Dietary Supplements / Q000633:toxicity*; D004305:Dose-Response Relationship, Drug; D004365:Drugs, Chinese Herbal / Q000633:toxicity*; D005277:Fenfluramine / Q000031:analogs & derivatives* / Q000633:toxicity; D007668:Kidney / Q000187:drug effects / Q000473:pathology; D008099:Liver / Q000187:drug effects / Q000201:enzymology / Q000473:pathology; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D014179:Neurotransmitter Uptake Inhibitors / Q000633:toxicity; D009929:Organ Size / Q000187:drug effects; D012701:Serotonin / Q000378:metabolism; D018675:Toxicity Tests / Q000379:methods*
D019440:Anti-Obesity Agents; D004365:Drugs, Chinese Herbal; D014179:Neurotransmitter Uptake Inhibitors; C493137:nitrosofenfluramine; D005277:Fenfluramine; D012701:Serotonin; D003577:Cytochrome P-450 Enzyme System